comparemela.com

Latest Breaking News On - Amarin corporation plc - Page 8 : comparemela.com

Amarin Partner HLS Therapeutics Completes Reimbursement

DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS.

United statesNew jerseyUnited arab emiratesKarim mikhailExchange commissionCanadian pharmaceutical allianceAmarin corporationEuropean unionDrug administrationUnited arabPrivate securities litigation reform actSecurities actNasdaq amrnAmarin corporation plc

Amarin Receives Reimbursement for VAZKEPA® in Sweden

Marks First Health Technology Assessment (HTA) Reimbursement in Europe and Initiation of Next Phase of the Company’s Growth Strategy Company Provides.

United statesHong kongUnited kingdomUnited arab emiratesNew zealandNew jerseySaudi arabiaKingdom of saudi arabiaAmarin europeLaurent abuafLisa defrancescoKarim mikhailInternational expansionCompany provides progress update on europeanCommunications amarin corporationDrug administration

Pharma Company Amarin Has a Key Asset and a Big Decision How Sarissa Capital Can Help It Move Forward

Activist fund Sarissa brings extensive knowledge and deep contacts in the health-care space, which could come in handy at Amarin.

United statesAlex dennerMedicines companyMochida pharmaceutical coAriad pharmaceuticals incSupreme courtEuropean unionAmarin corporation plcNovartis internationalAdventrx pharmaceuticalsMochida pharmaceuticalMarket valueSarissa capitalSarissa capital managementTakeda pharmaceuticalActivist spotlight

Pharma Company Amarin Has a Key Asset and a Big Decision How Sarissa Capital Can Help It Move Forward

Activist fund Sarissa brings extensive knowledge and deep contacts in the health-care space, which could come in handy at Amarin.

United statesAlex dennerMedicines companyMochida pharmaceutical coAriad pharmaceuticals incSupreme courtEuropean unionAmarin corporation plcNovartis internationalAdventrx pharmaceuticalsMochida pharmaceuticalMarket valueSarissa capitalSarissa capital managementTakeda pharmaceuticalActivist spotlight

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021

/PRNewswire/ The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of.

New yorkUnited statesNew jerseyJoseph leviJosephe leviLevi korsinskyEd korsinskyEduard korsinskyAmarin corporation plcFirm founding partnersUnited states district courtDistrict courtInstitutional shareholder serviceFounding partnersLevi amp korsinsky

vimarsana © 2020. All Rights Reserved.